Evidence map›Paper›PMID 20223821›Full record

ArticleThe Journal of biological chemistry2010

Protease-activated receptor-1 (PAR1) acts via a novel Galpha13-dishevelled axis to stabilize beta-catenin levels.

Hagit Turm, Myriam Maoz, Vered Katz, Yong-Jun Yin, Steffan Offermanns, Rachel Bar-Shavit

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 31 citations in OpenAlex.

  1. PARInternational journal of molecular sciences · 2025
    Article
  2. New Target(s) for RNF43 Regulation: Implications for Therapeutic Strategies.International journal of molecular sciences · 2024
    Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. G Protein-Coupled Receptors in Cancer.International journal of molecular sciences · 2016
    Review
  10. Wnt3a: functions and implications in cancer.Chinese journal of cancer · 2015
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. DVL as a scaffold protein capturing classical GPCRs.Communicative & integrative biology · 2010
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Hagit TurmDepartment of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem 91120, Israel.
Myriam MaozDepartment of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem 91120, Israel.
Vered KatzDepartment of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem 91120, Israel.
Yong-Jun YinDepartment of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem 91120, Israel.
Steffan OffermannsDepartment of Pharmacology, Max-Planck-Institute for Heart and Lung Research, Ludwigstrasse 43, 61231 Bad Nauheim, Germany.
Rachel Bar-ShavitDepartment of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem 91120, Israel. Electronic address: rachel.bar-shavit@ekmd.huji.ac.il.
Hadassah Medical Center · ILMax Planck Institute for Heart and Lung Research · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We have previously shown a novel link between hPar-1 (human protease-activated receptor-1) and beta-catenin stabilization. Although it is well recognized that Wnt signaling leads to beta-catenin accumulation, the role of PAR1 in the process is unknown. We provide here evidence that PAR1 induces beta-catenin stabilization independent of Wnt, Fz (Frizzled), and the co-receptor LRP5/6 (low density lipoprotein-related protein 5/6) and identify selective mediators of the PAR1-beta-catenin axis. Immunohistological analyses of hPar1-transgenic (TG) mouse mammary tissues show the expression of both Galpha(12) and Galpha(13) compared with age-matched control counterparts. However, only Galpha(13) was found to be actively involved in PAR1-induced beta-catenin stabilization. Indeed, a dominant negative form of Galpha(13) inhibited both PAR1-induced Matrigel invasion and Lef/Tcf (lymphoid enhancer factor/T cell factor) transcription activity. PAR1-Galpha(13) association is followed by the recruitment of DVL (Dishevelled), an upstream Wnt signaling protein via the DIX domain. Small interfering RNA-Dvl silencing leads to a reduction in PAR1-induced Matrigel invasion, inhibition of Lef/Tcf transcription activity, and decreased beta-catenin accumulation. It is of note that PAR1 also promotes the binding of beta-arrestin-2 to DVL, suggesting a role for beta-arrestin-2 in PAR1-induced DVL phosphorylation dynamics. Although infection of small interfering RNA-LRP5/6 or the use of the Wnt antagonists, SFRP2 (soluble Frizzled-related protein 2) or SFRP5 potently reduced Wnt3A-mediated beta-catenin accumulation, no effect was observed on PAR1-induced beta-catenin stabilization. Collectively, our data show that PAR1 mediates beta-catenin stabilization independent of Wnt. We propose here a novel cascade of PAR1-induced Galpha(13)-DVL axis in cancer and beta-catenin stabilization.

Indexed as

Adaptor Proteins, Signal TransducingAnimalsArrestinsbeta-Arrestin 2beta-Arrestinsbeta CateninCell LineDishevelled ProteinsGene SilencingGTP-Binding Protein alpha Subunits, G12-G13HumansImmunoprecipitationMiceMice, TransgenicPhosphoproteinsReceptor, PAR-1Adaptor Proteins, Signal TransducingARRB2 protein, humanArrb2 protein, mouseArrestinsbeta-Arrestin 2beta-Arrestinsbeta CateninDishevelled ProteinsGTP-Binding Protein alpha Subunits, G12-G13PhosphoproteinsReceptor, PAR-1

Identifiers

PMID20223821
PMCPMC2865281
OpenAlexW2127069079

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.